2022
DOI: 10.1002/adts.202200810
|View full text |Cite
|
Sign up to set email alerts
|

Rational Design of De Novo CCL2 Binding Peptides

Abstract: Chronic levels of inflammation lead to autoimmune diseases such as rheumatoid arthritis and atherosclerosis. A key molecular mediator responsible for the progression of these diseases is Chemokine C–C motif ligand 2 (CCL2), a homodimerized cytokine that dissociates into monomeric form and binds to the CCR2 receptor. CCL2, also known as monocyte chemoattractant protein‐1 (MCP‐1), attracts monocytes to migrate to areas of injury and mature into macrophages, leading to positive feedback inflammation with further … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…Aguas et al, subjected the binding site peptide sequence obtained from murine CCR2 to a series of homology models, energy calculations and Rosetta mutations to block chemokine C–C motif ligand 2 (CCL2) binding to the CCR2 receptor and proposed an 11 aa-long CCL2 blocking peptide (Aguas et al 2023 ). Mimics of the kinase-inhibitory region of Suppressors of Cytokine Signaling 1 (KIR-SOCS1) have been proposed for many inflammation-related diseases, and the peptidomimetic PS5 has been reported to downregulate the expression of NADPH oxidase (NOX1 and NOX4) and proinflammatory genes, and to reduce plaque size, lipid content and monocyte/macrophage accumulation in vivo (Manna et al 2020 , 2021a , b ).…”
Section: Current Strategies Of Therapeutic Peptides In Cadmentioning
confidence: 99%
“…Aguas et al, subjected the binding site peptide sequence obtained from murine CCR2 to a series of homology models, energy calculations and Rosetta mutations to block chemokine C–C motif ligand 2 (CCL2) binding to the CCR2 receptor and proposed an 11 aa-long CCL2 blocking peptide (Aguas et al 2023 ). Mimics of the kinase-inhibitory region of Suppressors of Cytokine Signaling 1 (KIR-SOCS1) have been proposed for many inflammation-related diseases, and the peptidomimetic PS5 has been reported to downregulate the expression of NADPH oxidase (NOX1 and NOX4) and proinflammatory genes, and to reduce plaque size, lipid content and monocyte/macrophage accumulation in vivo (Manna et al 2020 , 2021a , b ).…”
Section: Current Strategies Of Therapeutic Peptides In Cadmentioning
confidence: 99%
“…The hydrogen bonds were collected and summed for each frame for each residue using the CPPTRAJ H-bond command as described previously. 47 Non-H-bond intermolecular contacts were defined as two non-H atoms, one on each molecule, within 3 Å of each other and were collected per frame using the CPPTRAJ contact command. The Gibbs free energy of the model was estimated by using the sum of van der Waals and electrostatic interactions between all molecules within the simulation box.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
“…Hydrogen bonds were defined as interactions between an H atom on either the ligand or receptor and an N or an O atom on the opposite molecule within 3 Å of each other. The hydrogen bonds were collected and summed for each frame for each residue using the CPPTRAJ H-bond command as described previously . Non-H-bond intermolecular contacts were defined as two non-H atoms, one on each molecule, within 3 Å of each other and were collected per frame using the CPPTRAJ contact command.…”
Section: Experimental Sectionmentioning
confidence: 99%
See 2 more Smart Citations